Po-Ting Lin

Years Active: 2022-2023
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Po-Ting Lin, Wei-Kang Hung, Ying-Hsu Chang, Ming-Li Hsieh, Chung-Yi Liu, Liang-Kang Huang, Yuan-Cheng Chu, Hung-Cheng Kan, Po Hung Lin, Kai-Jie Yu, Cheng-Keng Chuang, Chun-Te Wu, See-Tong Pang, I-Hung Shao
Replacement Instead of Discontinuation of Bacillus Calmette-Guérin Instillation in Non-Muscle-Invasive Bladder Cancer. Cancers 15 (4) (2023)
Po-Ting Lin, Wei-Kang Hung, Ying-Hsu Chang, Ming-Li Hsieh, Chung-Yi Liu, Liang-Kang Huang, Yuan-Cheng Chu, Hung-Cheng Kan, Po Hung Lin, Kai-Jie Yu, Cheng-Keng Chuang, Chun-Te Wu, See-Tong Pang, I-Hung Shao
Replacement Instead of Discontinuation of Bacillus Calmette-Guérin Instillation in Non-Muscle-Invasive Bladder Cancer. Cancers 15 (4) (2023)
Po-Ting Lin, Wei-Kang Hung, Ying-Hsu Chang, Ming-Li Hsieh, Chung-Yi Liu, Liang-Kang Huang, Yuan-Cheng Chu, Hung-Cheng Kan, Po Hung Lin, Kai-Jie Yu, Cheng-Keng Chuang, Chun-Te Wu, See-Tong Pang, I-Hung Shao
Replacement Instead of Discontinuation of Bacillus Calmette-Guérin Instillation in Non-Muscle-Invasive Bladder Cancer. Cancers 15 (4) (2023)
Po-Ting Lin, Ming-Li Hsieh, Shih-Huan Su, Ying-Hsu Chang, Liang-Kang Huang, Yuan-Cheng Chu, Hung-Cheng Kan, Po Hung Lin, Kai Jie Yu, Cheng-Keng Chuang, Chun-Te Wu, See-Tong Pang, I-Hung Shao
Instillation Strategies for Non-Muscle-Invasive Bladder Cancer in the Bacillus Calmette-Guerin Shortage Era: A Simple Solution for BCG Discontinuation. Cancer management and research 14 (2022)

Po-Ting Lin.css-eqlu8i{font-size:small;padding-left:4px;}